GERMANY , 5 NOVEMBER 2021 –Dachser‘s Frankfurt air and sea freight branch has once again received certification from IATA’s Center of Excellence for Independent Validators in Pharmaceutical Logistics (CEIV Pharma), demonstrating its capabilities in logistics services for the life science and healthcare industry.
The transport of life science and health care products must meet exacting standards. Drugs and other pharmaceutical products are often temperature-sensitive, urgent shipments that must be handled in compliance with a complex regulatory environment. As an industry standard, CEIV Pharma certification covers the specific requirements of senders of pharmaceutical products with regard to safe, correct, and efficient air freight services. “This recertification confirms our expertise in the life science and healthcare sector,” says Timo Stroh, Head of Global Air Freight, who is also responsible for the Life Science and Healthcare Logistics Business Field Solution at Dachser. “It certifies the highest standards of service and quality, which we provide to our customers through consistent processes and a GDP-compliant network.”
The same standards apply for recertification as for initial certification. CEIV Pharma certification requires internal and external training, a review of procedures for handling temperature-controlled life science and healthcare shipments, and an extensive assessment of these complex processes by two independent auditors.
“We consider it absolutely essential to meet international standards in the worldwide transport of sensitive products,” Stroh explains. “This benefits our customers. Our location at Frankfurt Airport is immensely important for our global network. As an international air freight gateway with its own charter connections, its direct link to Dachser’s tightly knit overland transport network, and the established CEIV Pharma setup, the location is crucial for the further development of our industry solution for customers in the life science and healthcare sector,” Stroh says.
Discussion about this post